Evidence map›Paper›PMID 32499757›Full record

Trial reportFrontiers in endocrinology2020

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.

Georgia Colleluori, Rui Chen, Christie G Turin, Francesca Vigevano, Clifford Qualls, Biju Johnson, Sanjay Mediwala, Dennis T Villareal, Reina Armamento-Villareal

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Exploring the efficacy and safety of a novel standardized ashwagandha (Journal of psychopharmacology (Oxford, England) · 2023
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Nutritional aphrodisiacs: Biochemistry and Pharmacology.Current research in food science · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Georgia ColleluoriDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Rui ChenDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Christie G TurinDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Francesca VigevanoDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Clifford QuallsDivision of Mathematics and Statistics, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Biju JohnsonResearch Pharmacy, Michael E. DeBakey VA Medical Center, Houston, TX, United States.
Sanjay MediwalaDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Dennis T VillarealDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Reina Armamento-VillarealDivision of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Michael E. DeBakey VA Medical Center · USUniversity of New Mexico · US

Funding

Aromatase Inhibitors and Weight Loss in Severely Obese Men with HypogonadismR01HD093047 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI VILLAREAL, REINA C · 2017 to 2022
$1.9M
NICHD NIH HHS R01 HD093047
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Body CompositionBone DensityWeight LossAdultAgedAndrogensAromatase InhibitorsBiomarkersBone and BonesDouble-Blind MethodEstradiolFollow-Up StudiesHormone Replacement TherapyHumansHypogonadismMaleAndrogensAromatase InhibitorsBiomarkersEstradiolTestosteronearomatase inhibitorsbody compositionbone densitybone microarchitecturehypogonadismobesitysex hormonesweight loss

Identifiers

PMID32499757
PMCPMC7243137
OpenAlexW3024317829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.